 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Jul 25, 2015 |
| Title |
A Molecular Portrait Of High-Grade Ductal Carcinoma In Situ (DCIS) [RNA-seq] |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
DCIS is a non-invasive precursor lesion to invasive breast carcinoma. We still have no understanding on why only some DCIS lesions evolve to invasive cancer while others appear not to do so during the life span of the patient. Here, we performed full exome (tumor vs. matching normal), transcriptome and methylome analysis of 30 pure high-grade DCIS (HG-DCIS) and 10 normal breast epithelial samples. Sixty two percent of HG-DCIS cases displayed mutations affecting cancer driver genes or potential drivers. Mutations were observed affecting PIK3CA (21% of cases), TP53 (17%), GATA3 (7%), MLL3 (7%) and single cases of mutations affecting CDH1, MAP2K4, TBX3, NF1, ATM and ARID1A. Significantly, 83% of lesions displayed numerous large chromosomal copy number alterations, suggesting they might precede selection of cancer driver mutations. Integrated pathway-based modeling analysis of RNA-seq data allowed us to identify two DCIS subgroups (DCIS-C1 and DCIS-C2) based on their tumor intrinsic subtypes, proliferative, immune scores and in the activity of specific signaling pathways. The more aggressive DCIS-C1 (highly proliferative, basal-like or ERBB2+) displayed signatures characteristic of activated Treg cells (CD4+/CD25+/FOXP3+) and CTLA4+/CD86+ complexes indicative of a tumor-associated immune suppressive phenotype. Strikingly, all lesions showed evidence of TP53 pathway inactivation. Similarly ncRNA and methylation profiles reproduce changes observed post-invasion. Among the most significant findings we observed upregulation of lncRNA HOTAIR in DCIS-C1 lesions and hypermethylation of HOXA5 and specific SOX genes. We conclude that most HG-DCIS lesions, in spite of representing a pre-invasive stage of tumor progression, displayed molecular profiles indistinguishable from invasive breast cancer.
|
| |
|
| Overall design |
RNAs from 25 out of 30 (83%) pure HG-DCIS and 10 normal breast organoids (total 35 samples) were subjected to RNA-Seq analysis by using Illumina HiSeq2000 platform
Please note that description of samples employed for the NGS analyses including age, race, ER/PR immunohistochemistry results, ITIL/STIL scores and PAM50 classification is provided the 'Supplementary Data1_Samples data.xlsx' (available on Superseries record)
|
| |
|
| Contributor(s) |
Aldaz CM, Abba MC |
| Citation(s) |
26249178 |
| |
| Submission date |
May 26, 2015 |
| Last update date |
May 15, 2019 |
| Contact name |
C. Marcelo Aldaz |
| E-mail(s) |
maaldaz@mdanderson.org
|
| Phone |
512-237-9530
|
| Organization name |
The University of TX M.D. Anderson Cancer Center
|
| Department |
Molecular Carcinogenesis
|
| Lab |
Aldaz Lab
|
| Street address |
POB 389
|
| City |
Smithville |
| ZIP/Postal code |
78957 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
| Samples (35)
|
|
| This SubSeries is part of SuperSeries: |
| GSE69994 |
A Molecular Portrait Of High-Grade Ductal Carcinoma In Situ (DCIS) |
|
| Relations |
| BioProject |
PRJNA284949 |
| SRA |
SRP058722 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE69240_Preprocessed_datamatrix.csv.gz |
3.8 Mb |
(ftp)(http) |
CSV |
SRA Run Selector |
| Raw data are available in SRA |
| Processed data are available on Series record |
|
|
|
|
 |
Less...
More...